Karl-Johan Malmberg

22PUBLICATIONS
126CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)NeurogeneticsHaematological tumoursMolecular targetsGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Apr 17, 2026
CAR-NK Cells in B-cell Lymphoma: A New Frontier toward Accessible and Scalable Cellular Therapy.

|Mar 17, 2026
A genetic set-point for natural killer cells.

Pilar Maria Lanuza, Karl-Johan Malmberg

|Jun 12, 2025
Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines.

Jonida Kokiçi, Helena Arellano-Ballestero, Benjamin Hammond

|May 12, 2025
The innate power of natural killer cells in cancer therapy.

Ebba Sohlberg, Karl-Johan Malmberg

|Mar 22, 2025
Enhancing human NK cell antitumor function by knocking out SMAD4 to counteract TGFβ and activin A suppression.

Anna Rea, Sara Santana-Hernández, Javier Villanueva

|Sep 25, 2024
The G Protein-Coupled Receptor GPR56 Is an Inhibitory Checkpoint for NK Cell Migration.

Daniel Palacios, Rakesh Kumar Majhi, Edina K Szabo

Pageof 4

Frequent Collaborators

5 joint publications

Ebba Sohlberg

5 joint publications

Herman Netskar

4 joint publications

Minoru Kanaya

3 joint publications

Aline Pfefferle